Abstract
Azo dyes form substantial industrial pollutants owing to their poor biodegradation capacity. Present study identifies azo dye detoxifying strain of bacteria from waste water near textile industries. In order to identify the azo dye degrading strain, 16S rRNA gene was sequenced from the pure bacterial culture obtained from the samples collected from textile industry area at Erode in Tamil Nadu state of India. Two novel azo dye degrading bacteria were found out of 60 samples investigated, which were respectively named Sphingomonas sp strain EMBS022 and Sphingomonas sp strain EMBS023. Isolates of Sphingomonas sp strains - EMBS022 and EMBS023 were deposited in GenBank with accession numbers ‘KF951596’ & ‘KF951597’respectively. UNAFOLD and RNA fold web servers were employed to predict the secondary structure of 16s RNA of these strains. Free energy estimate for secondary structures of 16s rRNA of strains EMBS022 and EMBS023 were ΔG = -159.00 kcal/mol and ΔG = -159.90 kcal/mol, confirming the structures to be considerably stable.
Keywords: Azo dyes degrading bacteria, Sphingomonas species, Sphingomonas sp strain EMBS022 and EMBS023, 16S rRNA gene sequencing.
Current Bioinformatics
Title:Identification of Azo Dye Degrading Sphingomonas Strain EMBS022 and EMBS023 Using 16S rRNA Gene Sequencing
Volume: 10 Issue: 5
Author(s): Anuroopa G. Nadh, Uday Raj Akare, Priya Sharma, Pratibha Yadav, Srinivas Bandaru, Anuraj Nayarisseri and Achuthsankar S. Nair
Affiliation:
Keywords: Azo dyes degrading bacteria, Sphingomonas species, Sphingomonas sp strain EMBS022 and EMBS023, 16S rRNA gene sequencing.
Abstract: Azo dyes form substantial industrial pollutants owing to their poor biodegradation capacity. Present study identifies azo dye detoxifying strain of bacteria from waste water near textile industries. In order to identify the azo dye degrading strain, 16S rRNA gene was sequenced from the pure bacterial culture obtained from the samples collected from textile industry area at Erode in Tamil Nadu state of India. Two novel azo dye degrading bacteria were found out of 60 samples investigated, which were respectively named Sphingomonas sp strain EMBS022 and Sphingomonas sp strain EMBS023. Isolates of Sphingomonas sp strains - EMBS022 and EMBS023 were deposited in GenBank with accession numbers ‘KF951596’ & ‘KF951597’respectively. UNAFOLD and RNA fold web servers were employed to predict the secondary structure of 16s RNA of these strains. Free energy estimate for secondary structures of 16s rRNA of strains EMBS022 and EMBS023 were ΔG = -159.00 kcal/mol and ΔG = -159.90 kcal/mol, confirming the structures to be considerably stable.
Export Options
About this article
Cite this article as:
G. Nadh Anuroopa, Raj Akare Uday, Sharma Priya, Yadav Pratibha, Bandaru Srinivas, Nayarisseri Anuraj and S. Nair Achuthsankar, Identification of Azo Dye Degrading Sphingomonas Strain EMBS022 and EMBS023 Using 16S rRNA Gene Sequencing, Current Bioinformatics 2015; 10 (5) . https://dx.doi.org/10.2174/1574893610666151008012312
DOI https://dx.doi.org/10.2174/1574893610666151008012312 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pulmonary Manifestations of Rheumatoid Arthritis, Psoriatic Arthritis and Peripheral Spondyloarthritis: Prevalence, Diagnostic Approach and Treatment Options
Current Rheumatology Reviews Molecular Pharmacology and Pharmacogenomics of Artemisinin and its Derivatives in Cancer Cells
Current Drug Targets Pulmonary Hypertension and Systemic Diseases
Current Drug Targets - Inflammation & Allergy Cellular Functions of Vaults and their Involvement in Multidrug Resistance
Current Drug Targets Stem Cells and the Side Population Theory: A Critical Review
Current Tissue Engineering (Discontinued) Electrochemotherapy as First Line Cancer Treatment: Experiences from Veterinary Medicine in Developing Novel Protocols
Current Cancer Drug Targets A Critical Approach of Guideline Therapeutic Recommendations for NAFLD
Current Vascular Pharmacology Twist-BRD4 Complex: Potential Drug Target for Basal-like Breast Cancer
Current Pharmaceutical Design The Use of Intravenous Aminobisphosphonates for the Treatment of Pagets Disease of Bone
Mini-Reviews in Medicinal Chemistry Recent Advances and Perspectives in Liposomes for Cutaneous Drug Delivery
Current Medicinal Chemistry Roles of Perilipins in Diseases and Cancers
Current Genomics Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome
Current Pharmacogenomics Atorvastatin Sensitises Vascular Smooth Muscle Cells, but not Endothelial Cells, to TNF-α-induced Cell Death
Current Pharmaceutical Design Bortezomib in the Treatment of Cancer
Recent Patents on Anti-Cancer Drug Discovery Clinical Trial Update and Novel Therapeutic Approaches for Metastatic Prostate Cancer
Current Medicinal Chemistry Heparanase: Structure, Biological Functions, and Inhibition by Heparin-Derived Mimetics of Heparan Sulfate
Current Pharmaceutical Design The Endocannabinoid System in the Cancer Therapy: An Overview
Current Medicinal Chemistry Procyanidin B2 3,3″-di-O-gallate Inhibits Endothelial Cells Growth and Motility by Targeting VEGFR2 and Integrin Signaling Pathways
Current Cancer Drug Targets Prolylcarboxypeptidase Gene Expression in the Heart and Kidney: Effects of Obesity and Diabetes
Cardiovascular & Hematological Agents in Medicinal Chemistry Ribosome-inactivating Proteins from Root Tubers and Seeds of Trichosan-thes kirilowii and Other Trichosanthes Species
Protein & Peptide Letters